Drug Trial Radar · NCT00003771
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
Last checked: Nov 20, 2026Latest source record: Sep 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,300
Planned (sponsor's estimate)
Start
Sep 1997
Primary completion
Not stated
Study completion Feb 2004
Sponsor
- Lead sponsor
- Regional Oncologic CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Scandinavian Breast Group; ETOP IBCSG Partners Foundation; European Organisation for Research and Treatment of Cancer - EORTC
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- None
- Primary purpose
- Supportive care
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Hormone replacement therapy is effective for relieving symptoms of menopause. It is not yet known if hormone replacement therapy increases the risk of breast cancer recurrence in women previously treated for early stage breast cancer. PURPOSE: Randomized phase III trial to determine the risk of breast cancer recurrence in women with previous early stage breast cancer who are receiving hormone replacement therapy for menopause symptoms.
Conditions
- Breast Cancer
- Menopausal Symptoms
Interventions
therapeutic estradiolBiological
norethindrone acetateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
6 sites in 5 countries. Site status is shown where the registry gives one.
Helsinki University Central Hospital
Helsinki, Finland
Norwegian Radium Hospital
Oslo, Norway
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw, Poland
Karolinska Hospital
Stockholm, Sweden
Uppsala University Hospital
Uppsala, Sweden
Breast Center
Zurich, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.